The Effects of Dupilumab on Allergic Contact Dermatitis
Clinical trial NCT03935971 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03935971
- Sponsor
- Brigham and Women's Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-18
- Primary completion
- 2024-12-31
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.